Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.80% | $1.06M | €471.14B | 81.01% | 76 Outperform | |
| HSBC Holdings | 1.14% | $672.95K | £239.35B | 49.27% | 80 Outperform | |
| Toyota Motor | 1.09% | $645.74K | ¥49.85T | 37.39% | 80 Outperform | |
| BHP Group Ltd | 1.09% | $640.80K | £156.66B | 58.63% | 68 Neutral | |
| Novartis AG | 1.08% | $639.92K | CHF248.37B | 33.63% | 80 Outperform | |
| Roche Holding AG | 1.08% | $639.91K | CHF293.78B | 45.74% | 73 Outperform | |
| Mitsubishi UFJ Financial Group | 1.01% | $595.75K | ¥33.19T | 38.89% | 76 Outperform | |
| AstraZeneca | 1.00% | $590.80K | $324.18B | 29.86% | 80 Outperform | |
| Canadian Natural | 0.95% | $559.10K | C$124.30B | 54.83% | 81 Outperform | |
| Qualitas Real Estate Income Fund Units | 0.94% | $556.66K | AU$990.71M | -2.42% | 56 Neutral |